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Meniere’s disease is a common disease, that presents with recurrent vertigo and
cochlear symptoms. The pathology of Meniere’s disease was first reported to involve
endolymphatic hydrops in 1938. The endolymphatic sac is thought to have a role to
keep the hydrostatic pressure and endolymph homeostasis for the inner ear. As a surgery
for intractable Meniere’s disease, endolymphatic sac drainage with intraendolymphatic
sac application of large doses of steroids is performed to control the endolymphatic
hydrops and preserve or improve inner ear function. In the present study, to observe the
effect of this surgery, we calculated the endolymphatic space size using 3-Tesla magnetic
resonance imaging (MRI) 4 h after intravenous injection of gadolinium enhancement at
two time points: just before surgery and 2 years after. To reveal the condition of the
endolymphatic space, we constructed three-dimensional MR images semi-automatically
and fused the three-dimensional images of the total fluid space of inner ear and the
endolymphatic space. After fusing the images, we calculated the volume of the total
fluid space and endolymphatic space. Two years after surgery, 16 of 20 patients
(80.0%) showed relief from vertigo/dizziness and reductions in the ratio of the volume
of the endolymphatic size to the total fluid space of inner ear. Endolymphatic sac
drainage with intraendolymphatic sac application of large doses of steroids could control
vertigo/dizziness and decrease the endolymphatic hydrops. These results indicate that
endolymphatic sac drainage is a good treatment option for patients with intractable
Meniere’s disease. In addition, volumetric measurement of inner ear volume could be
useful for confirming the effect of treatments on Meniere’s disease.
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INTRODUCTION
Meniere’s disease (MD) is a chronic disease that presents with
recurrent vertigo, tinnitus, aural fullness, and fluctuating hearing
loss. Its pathology was first reported in 1938 to be endolymphatic
hydrops (EH) through two well-known temporal bone studies
(1, 2). Recently, some genes involved in immune responses have
been associated with clinical phenotypes of MD, MICA, and
TLR10 are associated with hearing loss progression in patients
with MD and the common variant rs11096955 in the TLR10
gene has been linked to the progression of hearing loss in
patients with bilateral MD (3). Li et al. used a molecular network-
based method using a random walk with restart algorithm to
predict genes potentially involved in MD (4) and found two
common allelic variants in the NFKB1 gene (rs3774937 and
rs4648011) to be associated with hearing loss progression in
patients with MD. However, the mechanisms underlying EH
generation (i.e., the relationship between stress and inner ear
water metabolism) have remained unclear. In addition, detection
of EH in patients with MD clinically using morphological
examinations is considered to be difficult. In 2007, Nakashima
et al. reported that 3-Tesla magnetic resonance imaging (MRI)
with gadolinium (Gd) enhancement could visualize the EH in
patients with MD (5). In 2016, we reported a method to evaluate
the endolymphatic space (ELS) size or EH with volumetric
measurement on three-dimensional MRI (6). A combination
of these two methods can allow objective and quantitative
evaluation of the EH.
When conservative medical treatments for MD fail, surgical
strategies are usually performed according to the treatment
guidelines for MD (7). The first surgical procedure of
endolymphatic drainage (ELSD) for MD was described by
Portmann in 1927, who opened the endolymphatic sac in order to
reduce the endolymphatic pressure (8). ELSD is still commonly
performed and yields complete vertigo control in 42–88% of
patients (9). MD is thought to be caused by immune, metabolic,
infectious, traumatic, or other insults to the inner ear associated
with a temporarily dysfunctional endolymphatic sac (10, 11).
Among these conditions, immune-mediated responses in the
inner ear endo-organs such as the endolymphatic sac, stria
vascularis, and spiral ligament are thought to be the main reasons
for the progression of MD (3, 12). Thus, systemic administration
and/or local perfusion of corticosteroids into the middle ear,
an immunosuppressive or anti-inflammatory therapy, are used
for the strategies for patients with intractable MD (13). In
2008, Kitahara et al. reported a new therapeutic strategy that
combined ELSD with intraendolymphatic sac application of
steroids for intractable MD, which controlled vertigo/dizziness
quite well (14). ELSD with/without intraendolymphatic sac
application of steroids is reported to be useful to control
vertigo/dizziness, but there is no paper that objectively and
quantitatively describes the condition of the ELS or EH after
ELSD.
In the present study, we performed volumetric measurement
of ELS at two time points—just before and 2 years after ELSD—
to objectively and quantitatively evaluate the condition of EH and
the effect of ELSD.
MATERIALS AND METHODS
The Medical Ethics Committee of Nara Medical University
approved this study (certificate number: 0889). All subjects gave
written informed consent in accordance with the Declaration of
Helsinki.
Patients
Twenty patients with a clinical diagnosis of MD according
to the 1995 American Academy of Otolaryngology–Head and
Neck Surgery (AAO-HNS) guidelines (7) and Bárány Society
criteria (15) were enrolled in the present study. The patients had
intractable MD, which was defined as the patients with recurrent
vertigo/dizziness for at least 6 months and whom systematic
medical treatments and psychological management had been
applied and had failed. They received ELSD at our university
hospital from February 2014 to July 2016.
Surgical Treatment
Kitahara et al. have reported the procedure used for ELSD with
steroids (14). Briefly, simple mastoidectomy was performed to
clearly expose the endolymphatic sac, which was opened with
an L-shaped incision and filled with 20mg of prednisolone
(Predonine; Shionogi, Japan). Then, a bundle of absorbable
gelatin film (Gelfilm; Pfizer, Japan) was inserted into the sac
and small pieces of absorbable gelatin sponge soaked in a
high concentration (3.3 mg/ml) of dexamethasone (Decadron,
Aspen Japan, Japan) were placed inside and outside the
sac.
Functional Examinations
Definitive vertigo/dizziness lasting more than 20min was
regarded as a vertigo attack according to the modified 1995
AAO-HNS guidelines (7). The frequency of vertigo before ELSD
(“before”) was calculated based on the number of vertigo attacks
during the 6months before ELSD. Frequency after ELSD (“after”)
was calculated based on the number of vertigo attacks during the
6-month period between 18 and 24 months after ELSD.
Functional Measurement
Hearing Test
Hearing function was measured by a pure-tone audiometer (AA-
78; Rion, Japan) and was evaluated based on the four-tone
average formulated by (a + b + c + d)/4 (a, b, c, d are hearing
levels at 0.5, 1.0, 2.0, and 4.0 kHz, respectively) according to the
modified 1995 AAO-HNS guidelines (7, 16). The worst hearing
level during the 6months before ELSDwas defined as the hearing
level before ELSD (“before”). The worst hearing level during the
6 months between 18 and 24 months after ELSD was used for
evaluation of the hearing level at 2 years after ELSD (“after”).
Differences in hearing levels >10 dB before and after ELSD
were regarded as “better.” Differences smaller than −10 dB were
regarded as “worse” and values in between better and worse were
considered to indicate “no change.”
Glycerol Test
The glycerol test (G-test) was performed to detect EH once
before ELSD (“before”) and once between 18 and 24 months after
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ELSD (“after”). Hearing function was measured just before oral
administration of glycerol (1.3 mg/kg) and 3 h later. This test
is considered positive in pure-tone audiometry if there is a 10-
dB improvement at two or more frequencies between 0.25 and
2.0 kHz.
Electrocochleography
We also performed electrocochleography (EcoG) to detect
EH at the same time as the G-test (“before” and “after”).
The silver-ball electrode for EcoG (COC-1; unique medical,
Japan) was placed on the upper wall of the deepest part
of the ear canal near the eardrum, and measurements were
obtained with click sounds using NeuropackX1 (Nihonkoden,
Japan). This test is considered positive if –SP/AP > 0.37 (the
average + 2 × standard deviation of healthy subjects) at our
hospital.
MRI Assessments
We performed MRI assessments just before ELSD (“before”) and
2 years after ELSD (“after”).
FIGURE 1 | Reconstruction procedure for color rendering and fusion of 3-D images of the inner ear fluid space and 3-D image of the endolymphatic space (ELS).
(A) Image of the total inner ear fluid space. (B) Image of the endolymphatic space. (C) Fusion images, axial view of the inner ear. (D) Fusion images, sagittal view of
the inner ear. (E) Fusion images, coronal view of the inner ear. The image of the total inner ear fluid space obtained by the T2-SPACE sequence was fused with the
image of endolymphatic space by PPI-PEI.
FIGURE 2 | Measurement of the volume of total inner ear fluid space and the endolymphatic space. (A) Axial field of view for the fusion image. (B) A graph for the
measurement of volume. The gray area on the color bar indicates a value of 0 on the graph (yellow line). A negative value indicates the volume of the endolymphatic
space.
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Pre-processing
Naganawa et al. (17) described using MRI 4 h after intravenous
injection of Gd as a tool for imaging EH. Briefly, in the
present study, MRI measurements were performed 4 h after
intravenous administration of a single dose (0.2 ml/kg or 0.1
mmol/ kg body weight) of Gd-diethylenetriaminepentaacetic
acid dimethylamide (Magnescope; Guerbet, Tokyo, Japan). A
3-Tesla MRI unit (MAGNETOM Verio; Siemens, Erlangen,
Germany) with a 32-channel array head coil was adopted in the
present study. Special sequences for revealing the endolymphatic
and perilymphatic fluid were used, as proposed by Naganawa
et al. (17).
All patients underwent the following protocols: heavily T2-
weighted (hT2W) MR cisternography (MRC) for an anatomical
total lymph fluid reference; hT2W 3-D fluid-attenuated inversion
recovery sequences with an inversion time of 2,250ms,
yielding positive perilymph images (PPI); and hT2W 3-D
inversion recovery with an inversion time of 2,050ms, yielding
TABLE 1 | The clinical characteristics of the study cohort.
Patient No. Laterality
(r/l)







1 r 48 5
2⋆ l 5 0
3 r 30 30
4⋆ l 2 40
5 r 240 40
6 l 192 60
7 r 60 20
8 r 11 4
9 l 240 14
10 l 16 1
11 r 34 7
12 l 40 21
13 l 100 90
14 r 140 0
15 r 6 3
16 l 60 15
17 l 180 25
18 l 60 7
19 l 9 6
20 r 70 240
The patient population consisted of four males and sixteen females, with ages ranging
from 23 to 76 years (median, 61.5 years). The interval between the first vertigo attack
or cochlear symptoms to MRI observation (Interval from onset to MRI) ranged from 2 to
240 months (median, 54.0 months). The interval between the latest vertigo attack to MRI
observation (Interval from latest vertigo to MRI) ranged from 0 to 240 days (median, 14.5
days). ⋆Patient #2 and 4 received an MRI scan 5 months and 2 months after onset for
their diagnosis, respectively. Subsequently, they suffered from recurrent episodic vertigo
for 6 months and then decided to receive ELSD after treatment for 6 months. However,
since the MRI had already been performed a few months prior, it was not repeated and
data from the first scan were utilized.
positive endolymph images (PEI). After image acquisition, we
obtained a hybrid image of the reversed image of the positive
endolymph signal and the negative image of the positive
perilymph signal after motion correction by subtracting PEI
from PPI, as proposed by Naganawa et al. (17, 18). In this
FIGURE 3 | The frequency of vertigo attacks before and after endolymphatic
sac drainage (ELSD). The frequency of vertigo attacks was 1.72 ± 1.46
times/month (mean ± standard deviation) before ELSD (before) and 0.08 ±
0.23 times/month after ELSD (after). The frequency decreased significantly
after ELSD. **p < 0.01, paired t-test.

























The frequency of vertigo before ELSD (“before”) was calculated based on the number
of vertigo attacks during the 6 months before ELSD. Frequency after ELSD (“after”) was
calculated based on the number of vertigo attacks during the 6-month period between
18 and 24 months after ELSD. After ELSD, 80% (16/20) of patients showed relief from
vertigo. Patients with circled numbers and the underlined values (#1, 10, 16, and 19) still
suffered from vertigo after ELSD.
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protocol, pixels with a negative value were regarded as the
ELS or EH.
Detailed scan parameters for hT2W MRC were as follows:
variable refocus flip angle 3-D-turbo spin-echo (sampling
perfection with application-optimized contrasts using different
flip angle evolutions [SPACE]); repetition time (TR), 4,400ms;
echo time (TE), 544ms; constant flip angle mode; matrix size, 322
× 384; slices per slab, 104; slice thickness, 1.0mm; field of view,
150.9× 180.0mm; and bandwidth, 434 Hz/pixel.
The area of ELS was first recognized on our workstation
(Virtual Place; AZE, Ltd., Tokyo, Japan) (Figure 1). Because ELS
voxels have negative signal values and the perilymph space voxels
have positive signal values, PPI and PEI were transferred, and
PEI images were subtracted from the PPI images using the fusion
program included with the software in our workstation. The
borderline between the gray area and the green area of the color
bar in our subtracted image was considered as zero-value in
our program (Figure 2). Additionally, the subtracted image was
FIGURE 4 | Changes in the result of hearing tests, glycerol tests (G-test), and
electrocochleography (EcoG). After ELSD, 25.0% of patients (5/20) showed
hearing improvement, 30.0% (6/20) showed negative conversion of G-test
findings, and 10.0% (2/20) showed negative conversion of EcoG findings.
There was no relationship between complete control and the results of the
hearing test, G-test, and EcoG.
consistent with the “PPI-PEI” image. In this process, areas that
had lower intensity than gray were recognized as the ELS areas.
Method of Fusing Images
Aswe reported in 2016 (6, 19), source images of the inner ear fluid
space (SPACE sequence image) and ELS (“PPI-PEI” image) were
reconstructed on our workstation. The inner ear fluid space was
manually identified from the surrounding structures by the object
extraction function and cut tool of the workstation. A high-
quality 3-D image was constructed semi-automatically using both
anatomical and tissue information by fusing the 3-D images of
the inner ear fluid space and 3-D ELS.
MR Imaging Evaluation
Conventional two-dimensional evaluation
Two neurotologists, who were blinded to the clinical progress
of the patients, evaluated the MRI findings. If their evaluations
differed, a third neurotologist made the final decision. For
evaluation of EH, the area of total fluid space in the cochlea and
vestibule wasmeasured on SPACE sequence image and the area of
ELS in the cochlea and vestibule was also measured on “PPI-PEI”
images using our workstation. Then, the area ratio of ELS to total
fluid space was calculated. The degrees of cochlear and vestibular
EH were classified as none, mild, or significant, according to
the criteria reported by Nakashima et al. (20) (Nakashima’s
criteria). When evaluating cochlear EH, one axial slice near the
modiolus was adopted. For evaluation of vestibular EH, one axial
slice that displayed the vestibule to the maximum extent was
adopted, but the ampulla of semicircular canal was excluded from
evaluation.
Patients classified as having no EH in the cochlea showed no
displacement of Reissner’s membrane. Those with mild cochlear
EH showed displacement of Reissner’s membrane, but the area
of the ELS did not exceed the area of the scala vestibuli.
In patients with significant cochlear EH, the area of the ELS
exceeded the area of the scala vestibuli. When the grade of
EH differed between the basal and upper turns of the cochlea,
the higher grade was adopted. In the vestibule, the grading
was determined from the ratio of the area of ELS to that of
FIGURE 5 | Changes in MRI images after ELSD. (A) Images of “PPI-PEI” before ELSD. (B) Images of “PPI-PEI” after ELSD. (C) Reconstructed 3D images of inner ear.
There are non-enhanced areas with Gd, suggesting the existence of EH, in the cochlea, vestibule, and semicircular canals (SCCs) of the image obtained before ELSD
(A). In contrast, non-enhanced areas in the vestibule and SCCs disappeared after ELSD (B). On reconstructed 3D image, light-browned area represents the
perilymphatic space and the black area represents ELS (C). White arrow indicates ELS (=EH) in the cochlea and arrow head indicates ELS (=EH) in the vestibule.
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the vestibular fluid space. Patients with no EH in the vestibule
had a ratio of ≤1:3, those with mild EH had ratios of 1:3–
1:2, and those with significant EH had a ratio >1:2. In the
present study, both mild and significant EH were defined as
“positive.”
Volumetric measurement and evaluation
Volumetric measurement of the inner ear was performed by
counting voxels: voxel size = matrix size × slice thickness.
First, both SPACE sequence image and “PPI-PEI” image were
activated on our workstation (Virtual Place) in the present
study. Second, components of the inner ear were identified on
SPACE sequence image by the borderlines between the inner
ear and the peripheral side of the acoustic nerve, between
the end of the cochlea and the vestibule, between the three
ampullae of semicircular canals (SCCs) and the vestibule, and
between the distal side of the common crus and the vestibule
using anatomical drawings as reported previously (19). Third,
counting voxels automatically on our workstation generated
volume of total fluid space. Fourth, the areas detected on SPACE
sequence image were transferred to “PPI-PEI” image on our
workstation: this was called “fusing.” Since MR images were
obtained from one scan, all images had the same coordinates.
Thus, we can perform “fusing” on workstations automatically
and precisely (Figure 2). Fifth, by counting voxels of minus
signals on “PPI-PEI” image, volumes of ELS were calculated.
In the present study, the signal of ELS was high on FLAIR
image (PPI) but almost zero on PEI image. Thus, ELS showed
minus signals on “PPI-PEI” image. Finally, the ELS volume in
the inner ear was measured and the ratio of the ELS area to
that of the inner ear fluid space (ELS ratio) was calculated.
The cochlear and vestibule areas were also measured by the
same method. To evaluate the effect of ELSD, we calculated the
proportion of ELS ratio (“after”/“before”). We performed these
measurements three times and the average was utilized in the
present study.
Statistical Analysis
For statistical analysis, we used one-way ANOVA for multiple
comparisons followed by pair-wise comparison with Tukey’s
post-hoc test and χ2 test or paired Student’s t-tests for two-group
comparisons. P-values under 0.05 were considered significant.
All the data above were treated statistically with SPSS version 14.0
(Chicago, IL).
RESULTS
The clinical characteristics of the study cohort are summarized in
Table 1.
The frequency of vertigo attacks was 1.72± 1.46 times/month
(average ± standard deviation) before and 0.08 ± 0.23
times/month after ELSD (Figure 3). The frequency decreased
significantly after ELSD (p= 3.0× 10−5, paired t-test). Complete
control of vertigo was achieved in 80.0% (16/20) of patients
(Table 2).
Functional Measurement
Hearing improvement was observed in 25.0% of patients
(5/20), negative conversion of G-test results in 30.0% (6/20),
and negative conversion of EcoG findings in 10.0% (2/20)
FIGURE 6 | Changes in the existence of endolymphatic hydrops (EH) on conventional two-dimensional evaluation. (A) The area ratio of EH in cochlea and vestibule
before and after ELSD among all 20 patients. (B) The area ratio of EH in cochlea and vestibule before and after ELSD among patients under complete of vertigo after
ELSD Among all patients, the area ratio of EH to total fluid space was 29.9 ± 17.6% (average ± standard deviation) in the cochlea and 46.5 ± 21.1% in the vestibule
before ELSD. After ELSD, the area ratio was 29.6 ± 11.1% in the cochlea and 39.9 ± 24.6% in the vestibule (A). There was no difference of area ratio between the
before and after groups. Among patients under complete control of vertigo, the area ratio was 32.0 ± 18.8% in the cochlea and 48.0 ± 21.7% in the vestibule before
ELSD. After ELSD, the area ratio was 27.9 ± 11.4% in cochlea and 34.6 ± 24.4% in the vestibule (B). There was no difference of the area ratio in the cochlea
between before and after ELSD but in the vestibule the area ratio significantly decreased after surgery. *p < 0.05, paired t-test; NS, not significant, paired t-test.
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(Figure 4). There was no relationship between complete
control and the results of the hearing test, G-test, and
EcoG.
MRI Assessments
Figures 5A,B showed typical changes in MRI images after
ELSD. There are non-enhanced areas with Gd, indicating the
existence of EH, in the cochlea, vestibule, and SCCs of the
image obtained before ELSD (Figure 5A). In contrast, non-
enhanced areas in the vestibule and SCCs disappeared after ELSD
(Figure 5B). Figure 5C showed the reconstructed 3D image of
the perilymphatic space and ELS.
Conventional Two-Dimensional Evaluation
Figure 6 andTable 3 show the area ratio of EH to total fluid space
(area ratio) in the cochlea and vestibule. There was no significant
difference in area ratio between before and after ELSD among
all patients (Figure 6A: NS, paired t-test). Among patients with
complete vertigo control, the area ratio of the cochlea tended
to decrease after ELSD but there were no significant differences
between before ELSD and after. In contrast, the area ratio of the
vestibule decreased significantly after ELSD (Figure 6B: p= 0.02,
paired t-test). The incident ratio of EH [by Nakashima’s criteria
(20)] is also described in Table 3. There was no relationship
between complete control of vertigo and the expression of EH
(Table 3).
Volumetric Measurement and Evaluation
Figure 7A shows the ELS ratios in the cochlea, vestibule, SCCs,
and whole inner ear (total) among all 20 patients. There were
no differences in the ELS ratios before and after ELSD (total: p
= 0.18, cochlea: p = 0.25, vestibule: p = 0.22, and SCCs: p =
0.37, paired t-test). Figure 7B shows the ELS ratio among patients
with complete control of vertigo (vertigo–). A comparison of all
patients showed that the ELS ratio in the cochlea and vestibule
after ELSD were significantly smaller than before ELSD (cochlea:
p = 0.03, vestibule: p = 0.008, paired t-test). The ELS ratio in
SCCs and in total tended to decrease after ELSD but showed no
significant differences between before and after ELSD (p= 0.06,
paired t-test). Figures 8A–D shows the changes in the ELS ratio
after ELSD in each patient. Almost all patients with complete
control of vertigo (vertigo–, gray lines) showed lower ELS ratios
after ELSD. In contrast, patients still suffering from vertigo
TABLE 3 | Changes in the existence of EH after ELSD.
Patient No. Cochlea Vestibule
Before After Before After
Area ratio (%) EH Area ratio (%) EH Area ratio (%) EH Area ratio (%) EH
26.9 Positive 25.9 Positive 59.1 Positive 53.7 Positive
2 36.4 Positive 27.3 Positive 27.3 Negative 28.0 Negative
3 44.0 Positive 26.1 Positive 67.8 Positive 53.3 Positive
4 71.4 Positive 12.5 Negative 37.5 Positive 7.4 Negative
5 20.0 Negative 36.0 Positive 23.8 Negative 25.9 Negative
6 60.0 Positive 46.2 Positive 44.4 Positive 0 Negative
7 28.6 Positive 36.8 Positive 25.9 Negative 33.3 Positive
8 17.6 Negative 13.0 Negative 23.8 Negative 8.7 Negative
9 26.3 Positive 22.7 Negative 66.7 Positive 14.2 Negative
22.2 Negative 38.4 Positive 36.8 Positive 55.0 Positive
11 10.7 Negative 25.8 Positive 56.0 Positive 42.4 Positive
12 0 Negative 20.0 Negative 26.3 Negative 31.5 Negative
13 7.7 Negative 13.6 Negative 24.1 Negative 11.5 Negative
14 42.9 Positive 29.2 Positive 81.8 Positive 61.5 Positive
15 30.8 Positive 50.0 Positive 48.0 Positive 83.3 Positive
28.6 Positive 44.4 Positive 14.3 Negative 75.0 Positive
17 41.7 Positive 36.8 Positive 73.3 Positive 39.1 Positive
18 30.8 Positive 17.4 Negative 81.0 Positive 37.0 Positive
8.3 Negative 36.8 Positive 51.7 Positive 60.0 Positive
20 42.9 Positive 33.3 Positive 60.0 Positive 76.2 Positive
The area of total fluid space and ELS in the cochlea and vestibule were measured and the area ratio of ELS to total fluid space was calculated (area ratio). EH was also evaluated by
Nakashima’s criteria. Both mild and significant EH were defined as “positive.” Before ELSD, the area ratio was 29.9 ± 17.6% (average ± standard deviation) in the cochlea and 46.5
± 21.1% in the vestibule. After ELSD, the area ratio was 29.6 ± 11.1% in the cochlea and 39.9 ± 24.6% in the vestibule. There was no difference of area ratio between before and
after (NS, not significant; paired t-test). The incident ratio of EH (positive) was 65.0% (13/20) in the cochlea, 65.0% (13/20) in the vestibule, and 80.0% (16/20) in total. In contrast, after
ELSD, the incident ratio was 70.0% (14/20) in the cochlea, 60.0% (12/20) in the vestibule, and 75.0% (15/20) in total. There were no significant differences between the “before” and
“after” values (NS, χ2-test). Patients with circled numbers still suffered from vertigo after ELSD, and the others were free from vertigo.
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FIGURE 7 | Changes in the ELS ratio after ELSD. (A) ELS ratio in the cochlea, vestibule, SCCs, and whole inner ear (total) before and after ELSD among all 20
patients. (B) ELS ratio in the cochlea, vestibule, SCCs, and total before and after ELSD among patients under complete control of vertigo after ELSD. The average of
ELS ratio before ELSD among all 20 patients was 22.2 in the cochlea, 41.6 in the vestibule, 26.4 in SCCs, and 24.8 in total. The average ELS ratio after ELSD among
all patients was 24.6 in the cochlea, 35.7 in the vestibule, 25.0 in SCCs, and 28.0 in total (A). There were no differences in the ELS ratio before and after ELSD (paired
t-test). The average ELS ratio before ELSD among patients showing complete control of vertigo was 25.9 in the cochlea, 45.7 in the vestibule, 28.8 in SCCs, and 23.7
in total. In contrast, the average ELS ratio after ELSD was 19.7 in the cochlea, 29.9 in the vestibule, 22.3 in SCCs, and 23.7 in total (B). There were significant
differences between the ELS ratios before and after ELSD in the cochlea and in the vestibule (paired t-test). On the other hand, the ELS ratio tended to decrease in
SCCs and in total but showed no significant differences. *p < 0.05, paired t-test, **p < 0.01, paired t-test; NS, not significant, paired t-test.
(vertigo+, dotted lines) showed increased ELS ratios after ELSD.
As seen in Figures 8E–I, the proportion of the ELS ratio of
vertigo– was significantly low in the cochlea, vestibule, SCCs, and
in total (cochlea, vestibule, and total: p < 0.01, one-way ANOVA,
Tukey test, SCCs: p < 0.05, one-way ANOVA, Tukey test).
DISCUSSION
In the present study, we first reported the volumetric change
of ELS after ELSD, suggesting the relationship between the
reduction of vertigo attack and decreased volume of ELS.
In 1938, Yamakawa in Japan and Hallpike in England reported
the pathology of MD to involve EH (1, 2). Since then, treatments
for MD have focused on reducing EH. In 1927 Portmann
introduced ELSD as an effective surgery to control EH (8). In
2008, Kitahara et al. modified the surgery with steroid instillation
into the opened sac and reported good results for vertigo control
and hearing (14). In contrast, some groups reported that ELSD
had debatable efficacy based on the results of placebo-control
studies (21, 22). Most studies on ELSD assessed its effects on
reducing the frequency of vertigo since the EH could not be
detected in live patients before Nakashima et al. introduced an
approach to visualize the EH using 3T MRI in 2007.
Some reports have discussed the changes in EH after ELSD
using 3T MRI and conventional two-dimensional evaluations
(9, 23). They reported that suppression of vertigo was not
always the result of a reduction in EH and that there was no
relationship between suppression of vertigo and reduction of
EH. In the present study, we also observed changes in EH using
conventional two-dimensional evaluation (Nakashima’s criteria)
and could not find a relationship between vertigo suppression
and EH. Then, we attempted volumetric measurement of the
ELS as reported by our group previously (19). In the present
study, 80.0% of patients experienced relief from vertigo after
ELSD (vertigo–). However, the remaining 20.0% still suffered
from vertigo (vertigo+). The ELS ratio of vertigo– patients had
significantly decreased after ELSD, while that of vertigo+ patients
did not show a significant change. We previously reported
the volume of ELS and ELS ratio of controls that had never
experienced vertigo/dizziness and never suffered ear disease; the
volume of ELS in controls was 10.3± 6.9 µl (average± standard
deviation) in the cochlea and 11.5 ± 7.1 µl in the vestibule.
The ELS ratio in the cochlea was 8.8 ± 5.3 and that in the
vestibule was 16.2 ± 9.0 (19). Compared with the controls, the
ELS ratio of vertigo– patients was still higher. Chung et al.
conducted a temporal bone study and reported that EH persisted
in all patients that received ELSD, even though the vertigo was
well-controlled (24). Thus, ELSD can reduce EH, but it cannot
achieve normalization. These findings suggest that if EH can
be reduced by ELSD, the patient’s vertigo could be controlled.
In the present study, 20.0% of patients still experienced vertigo
and showed an increased ELS ratio. The opened sac might
have closed over 2 years and could not reduce EH in these
patients.
Gürkov et al. reported betahistine treatment in six patients
with MD did not change EH, although their symptoms improved
significantly (25). Fiorino et al. also reported intra-tympanic
gentamicin therapy did not reduce EH even though vertigo
attacks were disappeared (26). They adopted two-dimensional
evaluations and reported no remarkable effect on EH despite
suppression of vertigo. In the present study, we first reported
the changes in EH using volumetric measurement and revealed
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FIGURE 8 | Comparison of the ELS ratio in patients showing complete control of vertigo with patients showing vertigo after ELSD. (A) ELS ratio in the cochlea.
(B) ELS ratio in the vestibule. (C) ELS ratio in SCCs. (D) ELS ratio in the cochlea, vestibule, and/or SCCs (total). (E) Proportion of ELS ratio in the cochlea after ELSD
(Continued)
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FIGURE 8 | compared to that before ELSD. (F) Proportion of ELS ratio in the vestibule after ELSD compared to that before ELSD. (G) Proportion of ELS ratio in the
SCCs after ELSD compared to that before ELSD. (H) Proportion of ELS ratio in total after ELSD compared to that before ELSD. (I) Comparison of proportion in
patients showing complete control of vertigo (vertigo–) with patients showing vertigo after ELSD (vertigo+). Almost all vertigo– patients showed decreased ELS ratios
for the cochlea, vestibule, SCCs, and total after ELSD. In contrast, all vertigo+ patients showed increased ELS ratios after ELSD (A–D). The proportions in ELS ratios
in the vertigo– patients were significantly lower than those in vertigo+ patients in the cochlea, vestibule, SCCs, and total (E–I). Gray lines: vertigo– patients; dotted
lines: vertigo+ patients; black diamonds: vertigo– patients; white diamonds: vertigo+ patients. *p < 0.05, one-way ANOVA, Tukey test, **p < 0.01, one-way ANOVA,
Tukey test.
significant changes in EH in the vertigo– group. Assessment of
the EH using this method would allow identification of changes
in and the effects on EH after treatment (i.e., isosorbide, steroids,
Meniett) and help clinicians decide whether to continue the
treatment.
The limitation of the present study is the small number
of patients. Because ELSD can often reduce the frequency of
vertigo, we experienced difficulty in collecting data on patients
showing vertigo even after ELSD. Nevertheless, by comparing
the proportions of the ELS ratio of “after treatment” and “before
treatment” groups, we could understand the extent to which EH
could be reduced to control vertigo. This could facilitate future
progress in the field of treatment for MD.
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